Vivek PharmaChem (India) Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Vivek PharmaChem

DeciZen not available for IPO

10 Year X-Ray of Vivek PharmaChem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'19Mar'20Mar'21TTM
ROCE % 14.3%14.6%13.2%9.5%8.4%13.3%12.9%16.1%19.5%14.2%-
Value Creation
Index
0.00.0-0.1-0.3-0.4-0.1-0.10.20.40.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 4949.574.488.676.699.199.5134211149149
Sales YoY Gr.-0.9%50.3%19.2%-13.6%29.4%0.4%35%57.3%-29.5%-
Adj EPS 0.90.30.60.50.7-1.115.25.84.84.8
YoY Gr.--69.7%137%-21.9%34%-265.7%NA409.8%12.3%-17.5%-
BVPS (₹) 9.69.61111.512.311.112.124.13034.834.8
Adj Net
Profit
1.30.40.90.71-1.61.57.48.36.97
Cash Flow from Ops. 8.1-2.612.930.110.81717.912.99.7-
Debt/CF from Ops. 1.7-7.62.814369.853.333.33.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 13.1%14.2%14.4%-29.5%
Adj EPS 20.7%48.4%67.8%-17.5%
BVPS15.4%23.2%42.1%16.1%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'19Mar'20Mar'21TTM
Return on
Equity %
9.72.86.24.45.6-9.58.828.721.614.913.9
Op. Profit
Mgn %
13.915.312.113.813.414.115.915.311.712.3NAN
Net Profit
Mgn %
2.60.81.20.81.3-1.61.55.53.94.64.6
Debt to
Equity
11.42.32.52.23.43.31.610.7-
Working Cap
Days
1481691411251371241481371341880
Cash Conv.
Cycle
465152608058543835440

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Vivek PharmaChem (India) Ltd.

Standalone Consolidated
TTM EPS (₹) 4.8 -
TTM Sales (₹ Cr.) 149 -
BVPS (₹.) 34.8 -
Reserves (₹ Cr.) 35 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 14.3
Face Value (₹) 10
Industry PE 44.3

Management X-Ray of Vivek PharmaChem:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Vivek PharmaChem

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'19Mar'20Mar'21
Sales49.0349.4674.3688.6476.6199.1099.47134.23211.18148.87
Operating Expenses 42.3441.9165.3776.4566.3285.1183.67113.73186.54130.55
Manufacturing Costs8.678.531.580011.2113.4821.8429.1621.19
Material Costs26.1124.6552.1761.6056.7660.0458.2872.26123.0685.62
Employee Cost 1.761.962.893.453.233.933.876.7187.57
Other Costs 5.806.778.7211.406.339.938.0412.9226.3316.18
Operating Profit 6.697.558.9912.1910.3013.9915.8020.5024.6418.32
Operating Profit Margin (%) 13.6%15.3%12.1%13.8%13.4%14.1%15.9%15.3%11.7%12.3%
Other Income 0.020.280.060.090.390.050.240.490.120.65
Interest 1.752.063.223.693.234.795.936.157.174.86
Depreciation 2.443.413.487.065.965.776.817.937.847.20
Exceptional Items 0000000000
Profit Before Tax 2.522.352.361.531.503.483.316.919.756.92
Tax 1.331.981.440.790.465.061.85-0.511.440.04
Profit After Tax 1.200.370.920.741.04-1.581.457.428.326.88
PAT Margin (%) 2.4%0.8%1.2%0.8%1.4%-1.6%1.5%5.5%3.9%4.6%
Adjusted EPS (₹)0.80.30.60.50.7-1.11.05.25.84.8
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'19Mar'20Mar'21

Equity and Liabilities

Shareholders Fund 13.6213.6315.7016.4417.4815.8217.2734.3742.6949.56
Share Capital 9.879.8714.2514.2514.2514.2514.2514.2514.2514.25
Reserves 3.753.761.442.193.231.573.0220.1228.4435.31
Minority Interest0000000000
Debt13.8419.4730.5837.5534.4648.6849.8045.5732.5325.86
Long Term Debt13.8415.8926.1224.3523.5932.2638.2230.4925.3725.86
Short Term Debt03.584.4613.2010.8716.4211.5815.087.160
Trade Payables13.398.2116.966.418.9514.5419.303251.0931.09
Others Liabilities 7.166.1620.4020.6512.7117.4120.1622.0422.8917.21
Total Liabilities 4847.4783.6381.0573.6096.46106.53133.99149.20123.73

Fixed Assets

Gross Block40.0740.0969.9770.0966.5984.91105.40122.39124.87125.26
Accumulated Depreciation15.1518.562228.9833.0638.9045.7268.5476.3883.29
Net Fixed Assets24.9221.5347.9741.1133.5346.0159.6853.8548.5041.97
CWIP 0000000000.02
Investments 0000000000
Inventories4.572.936.894.744.918.556.5115.9913.809.73
Trade Receivables15.4616.8725.6122.2421.8926.4932.8648.6971.7749.29
Cash Equivalents 0.851.030.6610.168.759.710.891.662.096.62
Others Assets2.205.112.492.814.525.696.5913.8013.0516.09
Total Assets 4847.4783.6381.0573.6096.46106.53133.99149.20123.73

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'19Mar'20Mar'21
Cash Flow From Operating Activity 8.09-2.5612.932.960.1010.7516.9717.9212.879.65
PBT 2.522.352.361.531.503.483.316.919.756.92
Adjustment 3.294.954.457.054.4710.5212.5013.5814.9511.02
Changes in Working Capital 3.61-7.537.57-5.15-5.56-2.551.85-1.26-10.28-7.19
Tax Paid -1.33-2.34-1.44-0.47-0.31-0.70-0.68-1.32-1.55-1.09
Cash Flow From Investing Activity -8.36-0.03-29.81-0.441.59-19.23-20.98-9.82-0.17-1.16
Capex -8.36-0.03-29.92-0.193.11-18.34-20.49-9.14-2.48-0.61
Net Investments 0000000000
Others 000.11-0.25-1.52-0.90-0.50-0.682.31-0.55
Cash Flow From Financing Activity -3.322.7716.516.97-3.109.44-4.81-7.96-12.26-3.96
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing -3.372.3700000000
Interest Paid 00000-4.79-5.93-6.05-7.14-4.45
Dividend Paid 0000000000
Others 0.050.4016.516.97-3.1014.231.11-1.90-5.120.49
Net Cash Flow -3.590.18-0.379.49-1.400.96-8.830.140.444.53
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'19Mar'20Mar'21
Ratios
ROE (%)9.192.756.244.626.14-9.498.7828.7321.5914.91
ROCE (%)14.2714.5913.159.538.3713.2612.9116.1219.5314.16
Asset Turnover Ratio1.131.081.21.151.051.251.061.381.71.23
PAT to CFO Conversion(x)6.74-6.9214.0540.1N/A11.72.421.551.4
Working Capital Days
Receivable Days107114999399831019091131
Inventory Days26262322222326252325
Payable Days14616088694971106130123175

Vivek PharmaChem (India) Ltd Stock News

Vivek PharmaChem (India) Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Vivek PharmaChem on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Vivek PharmaChem stood at ₹0.00.
The latest P/E ratio of Vivek PharmaChem as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Vivek PharmaChem as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Vivek PharmaChem is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vivek PharmaChem is ₹148.9 ( Cr.) .

About Vivek PharmaChem (India) Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.